Scopus BioPharma Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2020 to Q2 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Scopus BioPharma Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2020 to Q2 2023.
  • Scopus BioPharma Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 11, 2023 was 42.1M shares, a 99.5% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 42.1M +21M +99.5% Aug 11, 2023 10-Q 2023-08-11
Q1 2023 39.6M +18.5M +87.7% Apr 10, 2023 10-K 2023-04-14
Q4 2022 21.1M Nov 21, 2022 10-Q 2022-11-21
Q2 2022 21.1M +3M +16.6% Aug 12, 2022 10-Q 2022-08-15
Q1 2022 21.1M +5.37M +34.1% Apr 8, 2022 10-K 2022-04-15
Q3 2021 18.1M Nov 12, 2021 10-Q 2021-11-12
Q2 2021 18.1M Aug 6, 2021 10-Q 2021-08-13
Q1 2021 15.7M Mar 15, 2021 10-K 2021-03-29
Q4 2020 14.6M Jan 25, 2021 10-Q/A 2021-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.